Patents by Inventor WangHua Gong

WangHua Gong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amyloid beta is a ligand for FPR class receptors
    Publication number: 20050130890
    Abstract: The invention relates to the discovery that amyloid ? is a ligand for FPR class receptors, which mediate the inflammation associated with Alzheimer's disease.
    Type: Application
    Filed: April 23, 2004
    Publication date: June 16, 2005
    Inventors: Ji Wang, Yingying Le, WangHua Gong, Hiroshi Yazawa, Zu-Xi Yu, Joost Oppenheim, Philip Murphy
  • Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection
    Patent number: 6808877
    Abstract: The present invention relates to the discovery of molecules that inhibit viral infection and promote a host immune response to a pathogen. More specifically, the invention disclosed herein concerns molecules that interact with a FPR class receptor, inhibit HIV infection, and stimulate an inflammatory response in a subject. Embodiments of the invention include biotechnological tools, prophylactics, therapeutics, and methods of use of the foregoing, for the study, treatment, and prevention of HIV infection and the induction of an inflammatory response in a subject.
    Type: Grant
    Filed: July 17, 2002
    Date of Patent: October 26, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Ji-Ming Wang, Yingying Le, WangHua Gong, Bao Qun Li, Thomas Rogers, Philip Murphy, Joost J. Oppenheim
  • Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection
    Publication number: 20030147883
    Abstract: The present invention relates to the discovery of molecules that inhibit viral infection and promote a host immune response to a pathogen. More specifically, the invention disclosed herein concerns molecules that interact with a FPR class receptor, inhibit HIV infection, and stimulate an inflammatory response in a subject. Embodiments of the invention include biotechnological tools, prophylactics, therapeutics, and methods of use of the foregoing, for the study, treatment, and prevention of HIV infection and the induction of an inflammatory response in a subject.
    Type: Application
    Filed: July 17, 2002
    Publication date: August 7, 2003
    Inventors: Ji-Ming Wang, Yingying Le, WangHua Gong, Bao Qun Li, Thomas Rogers, Philip Murphy, Joost J. Oppenheim